Inflammatory bowel disease and associated cardiovascular disease outcomes: A systematic review
Vikash Jaiswal(Unknown), David Song(New York Hospital Queens), Mehak Dagar(Swami Rama Himalayan University), Zouina Sarfraz(Fatima Jinnah Medical University), Swatika Butey(Government Medical College), Helen Huang(University College Hospital), Dipansha Maroo(Maulana Azad Medical College), Dattatreya Mukherjee(Raiganj University), Song Peng Ang(University of Arizona), Abhigan Babu Shrestha(Dinajpur Medical College), Jia Ee Chia(Texas Tech University), Muhammed Hanif(SUNY Upstate Medical University), Nitya Batra(Jacksonville College), Srushti Patel(Children's Hospital of Philadelphia), Sidra Naz(The University of Texas MD Anderson Cancer Center), Evbayekha O. Endurance(St. Luke's Hospital), Nishchita Raj(B.P. Koirala Institute of Health Sciences)
Cited by 37
Related Papers
Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment
|Clinical Cancer Research|2009|103
Early Detection of Subclinical Visual Damage After Blast-Mediated TBI Enables Prevention of Chronic Visual Deficit by Treatment With P7C3-S243
|Investigative Ophthalmology & Visual Science|2014|91
Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention
|Tropical parasitology|2016|80
Unveiling Nature's potential: Promising natural compounds in Parkinson's disease management
|Parkinsonism & Related Disorders|2023|58
COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review
|Journal of Primary Care & Community Health|2021|48